Erin Borger

Amministratore Delegato presso ExThera Medical Corp.

43 anni

Health Technology

Consumer Services

Health Services

Profilo

Erin R.
Borger is currently the Chief Executive Officer & Director at ExThera Medical Corp.
Mr. Borger previously worked as a Director at the National Parkinson Foundation, Inc. Mr. Borger also served as an Independent Director at Longeveron, Inc. Mr. Borger completed their undergraduate degree at Wofford College.

Posizioni attive di Erin Borger

Società	Posizione	Inizio
ExThera Medical Corp. ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA.	Amministratore Delegato	15/11/2023

Tutte le posizioni attive di Erin Borger

Precedenti posizioni note di Erin Borger

Società	Posizione	Fine
LONGEVERON INC.	Direttore/Membro del Consiglio	09/06/2023
National Parkinson Foundation, Inc.	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Erin Borger

Formazione di Erin Borger

Wofford College

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Erin Borger

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
LONGEVERON INC.	Health Technology

Aziende private	2
National Parkinson Foundation, Inc.	Health Technology
ExThera Medical Corp. ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA.	Health Services